Sebastian Kreuz

Investor profile

Sebastian Kreuz

Corporate VC & Head of Boehringer Ingelheim Venture Fund EU at Boehringer Ingelheim

Sebastian Kreuz is a Head of Boehringer Ingelheim Venture Fund EU at Boehringer Ingelheim, whose known portfolio counts 9 companies.

Is Sebastian Kreuz a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

seb***@***.comPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Affiliated funds' portfolios

Head of Boehringer Ingelheim Venture Fund EU at Boehringer Ingelheim, whose known portfolio counts 9 companies

  • Otto
  • Ilara Health
  • Promethera Biosciences
  • Click Therapeutics
  • MabVax Therapeutics
  • NBE-Therapeutics
  • Yale Cancer Center
  • Greybox Solutions
  • Proxygen

Investor Profile

Founders in the listed sectors AI and Healthcare, and focus areas AI Applications, Animal Health, Biotech and Digital Health fall inside that listing.

Boehringer Ingelheim appears in Growth, Late-Stage and Series A rounds across its known deals.

The firm portfolio and the focus above give founders context on whether Sebastian Kreuz matches their raise.

Colleagues at Boehringer Ingelheim

Frequently asked questions

Who is Sebastian Kreuz?

Sebastian Kreuz is a corporate venture investor based in Ingelheim am Rhein, Rhineland-Palatinate, Germany, listed as Head of Boehringer Ingelheim Venture Fund EU at Boehringer Ingelheim. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Sebastian Kreuz personally.

What does Sebastian Kreuz invest in?

Listed sectors include AI and Healthcare; listed focus areas include AI Applications, Animal Health, Biotech and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Sebastian Kreuz invest at?

Boehringer Ingelheim appears in Growth, Late-Stage and Series A rounds across its known deals, and Sebastian Kreuz is listed there as Head of Boehringer Ingelheim Venture Fund EU. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Sebastian Kreuz listed at?

Sebastian Kreuz is listed as Head of Boehringer Ingelheim Venture Fund EU at Boehringer Ingelheim. 10 other people in the database share a firm with Sebastian Kreuz.

How do I contact Sebastian Kreuz?

An email address, a phone number and a LinkedIn page are on file for Sebastian Kreuz. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal